1. Home
  2. VYNE vs MOGO Comparison

VYNE vs MOGO Comparison

Compare VYNE & MOGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYNE
  • MOGO
  • Stock Information
  • Founded
  • VYNE 2003
  • MOGO 2003
  • Country
  • VYNE United States
  • MOGO Canada
  • Employees
  • VYNE N/A
  • MOGO N/A
  • Industry
  • VYNE Biotechnology: Pharmaceutical Preparations
  • MOGO
  • Sector
  • VYNE Health Care
  • MOGO
  • Exchange
  • VYNE Nasdaq
  • MOGO Nasdaq
  • Market Cap
  • VYNE 41.9M
  • MOGO 35.1M
  • IPO Year
  • VYNE 2018
  • MOGO N/A
  • Fundamental
  • Price
  • VYNE $2.49
  • MOGO $1.35
  • Analyst Decision
  • VYNE Strong Buy
  • MOGO Strong Buy
  • Analyst Count
  • VYNE 2
  • MOGO 1
  • Target Price
  • VYNE $6.88
  • MOGO $6.00
  • AVG Volume (30 Days)
  • VYNE 70.8K
  • MOGO 99.4K
  • Earning Date
  • VYNE 11-07-2024
  • MOGO 11-06-2024
  • Dividend Yield
  • VYNE N/A
  • MOGO N/A
  • EPS Growth
  • VYNE N/A
  • MOGO N/A
  • EPS
  • VYNE N/A
  • MOGO N/A
  • Revenue
  • VYNE $493,000.00
  • MOGO $30,995,226.00
  • Revenue This Year
  • VYNE $28.30
  • MOGO N/A
  • Revenue Next Year
  • VYNE N/A
  • MOGO $3.73
  • P/E Ratio
  • VYNE N/A
  • MOGO N/A
  • Revenue Growth
  • VYNE 39.27
  • MOGO N/A
  • 52 Week Low
  • VYNE $1.57
  • MOGO $0.94
  • 52 Week High
  • VYNE $3.43
  • MOGO $2.25
  • Technical
  • Relative Strength Index (RSI)
  • VYNE 40.82
  • MOGO 46.99
  • Support Level
  • VYNE $2.34
  • MOGO $1.33
  • Resistance Level
  • VYNE $2.69
  • MOGO $1.46
  • Average True Range (ATR)
  • VYNE 0.19
  • MOGO 0.09
  • MACD
  • VYNE -0.04
  • MOGO -0.03
  • Stochastic Oscillator
  • VYNE 13.79
  • MOGO 7.32

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established global corporations and innovative fintech companies in Europe and Canada.

Share on Social Networks: